| Application no. and date | 16718705.3 (espacenet) (Federated) (European Patent Register), 20160427 | | Patent/reg. no. and date | DK/EP 3288581, 20201111 | | Publication date | 20180307 | | Priority no. and date | GB 201507100, 20150427, GB 201603663, 20160302, GB 201603731, 20160303 | | EP pub. no. and date |
EP 3288581 20180307 | | Effective date | | | Applicant/owner | Achilles Therapeutics UK Limited, 245 Hammersmith Road
London W6 8PW, GB | | Applicant ref. no. | 1566667 | | Inventor | MCGRANAHAN, Nicholas, c/o Cancer Research Technology Limited
2 Redman Place
London E20 1JQ, GB,
QUEZADA, Sergio, c/o Cancer Research Technology Limited
2 Redman Place
London E20 1JQ, GB,
ROSENTHAL, Rachel, c/o Cancer Research Technology Limited
2 Redman Place
London E20 1JQ, GB,
SWANTON, Charles, c/o Cancer Research Technology Limited
2 Redman Place
London E20 1JQ, GB,
PEGGS, Karl, c/o Cancer Research Technology Limited
2 Redman Place
London E20 1JQ, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) | | Title | FREMGANGSMÅDE TIL BEHANDLING AF CANCER | | Int. application no. | EP2016059401 | | Int. publication no. | WO2016174085 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
